Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 15;5(2):154-61.
eCollection 2015.

Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma

Yukako Ichimiya  1 , Krishna Alluri  1 , Charles Marcus  1 , Simon Best  2 , Christine H Chung  3 , Rathan M Subramaniam  4
Affiliations

Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma

Yukako Ichimiya et al. Am J Nucl Med Mol Imaging. .

Abstract

The objective of this study is to establish the utilization trends of CT, MRI, and FDG-PET/CT for evaluation of oropharyngeal squamous cell carcinoma (OPSCC) patients. A total of 173 patients with newly diagnosed stage III or IV OPSCC between 2003 and 2009 were included. Frequency of imaging modality use, divided into four time periods (2003-04, 2005-06, 2007-08 and 2009), was evaluated. For initial staging, percentage of PET/CT use was 64.6%, 87.5%, 94.1% and 96.3%, with an increasing trend (p < 0.001). The CT (p = 0.762) and MRI (p = 0.224) use demonstrated no change in trend. For post-treatment imaging, percentage of PET/CT use was 59.5%, 68.6%, 89.7% and 100%, with an increasing trend (p < 0.001). The CT use demonstrated a decreasing trend (p = 0.004) and MRI showed no trend change (p = 0.231). PET/CT is used with an increasing trend for initial staging and has become a central imaging modality for follow up evaluation after treatment, for advanced OPSCC.

Keywords: FDG; Oropharyngeal squamous cell carcinoma (OPSCC); PET/CT; cancer; magnetic resonance imaging (MRI).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentage of imaging modalities used at initial staging (n = 173).
Figure 2
Figure 2
A: Percentage of imaging modalities used at initial staging in patients who received radiation therapy (n = 96). B: Percentage of imaging modalities used at initial staging in patients treated with Surgery (n = 70).
Figure 3
Figure 3
Percentage of imaging modalities used post-treatment (n = 148).
Figure 4
Figure 4
A: Percentage of imaging modalities used post-treatment in patients received radiation therapy (n = 96). B: Percentage of imaging modalities used post-treatment in patients treated with surgery (n = 70).
Figure 5
Figure 5
Value of contrast enhanced FDG PET/CT- Axial PET (A), fused PET/CT (B), contrast enhanced CT (C) images of a 60 year old gentleman with HPV associated squamous cell carcinoma of the tongue base who underwent a staging FDG PET/CT study. PET/CT shows hypermetabolic base of tongue mass (SUVmax – 4.6), hypermetabolic right level II cervical node. The contrast enhanced CT of the neck showed no invasion of the tongue muscles from the primary tumor and subcentimeter right level II cervical node. Contrast enhanced PET/CT provided the clinical information about the primary tumor as well as the nodal metastasis required for management decisions in a single imaging study.
See this image and copyright information in PMC

References

    1. American Cancer Society. What are the key statistics about oral cavity and oropharyngeal cancers. Accessed on 23th March, 2013.
    1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Head and Neck Cancers version1. 2012.
    1. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, Creson N, Lindholm J, Ye W, Dalianis T, Munck-Wikland E. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119:2620–2623. - PubMed
    1. Kubicek GJ, Champ C, Fogh S, Wang F, Reddy E, Intenzo C, Dusing RW, Machtay M. FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol. 2010;2:19. - PMC - PubMed
    1. Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol. 2009;70:382–392. - PubMed

LinkOut - more resources